Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Sea 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place To Work
Tech
Tech
Ai
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-suite
Ceo Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Johnson & Johnson
Johnson & Johnson
Page 2 of 18
Newsletters
J.M. Smucker’s CFO explains how sales of Uncrustables grew 22% in the latest quarter—and is on its way to being a $1 billion brand
By
Sheryl Estrada
December 7, 2023
Newsletters
His dad worked on the factory floor at Johnson & Johnson. Now he’s the CFO
By
Sheryl Estrada
December 6, 2023
Finance
13 inflation-proof stocks to buy for 2024
By
Will Daniel
and
Scott DeCarlo
November 28, 2023
Health
Facing 50,000-plus lawsuits linking Baby Powder to cancer, Johnson & Johnson mulls a third bankruptcy filing
By
Jef Feeley
and
Bloomberg
October 26, 2023
Leadership
Generative AI is top of mind for all types of leaders, from Treasury Secretary Janet Yellen to J&J CEO Joaquin Duato
By
Fortune Editors
October 11, 2023
Finance
J&J CEO Joaquin Duato discusses how he leads during challenging times and why the next decade will be the golden era for health innovation
By
Fortune Editors
October 3, 2023
Health
Johnson & Johnson hit by 11,000 more lawsuits linking Baby Powder to cancer after judge throws $9 billion settlement case
By
Jef Feeley
and
Bloomberg
September 28, 2023
Health
McKinsey agrees to pay $230m to settle suits claiming it fueled the opioid epidemic by advising drugmakers like Purdue how to sell painkillers
By
Joel Rosenblatt
and
Bloomberg
September 27, 2023
Newsletters
This J&J exec sold Tylenol and Listerine. Now she runs its $27 billion medtech business
By
Emma Hinchliffe
and
Joey Abrams
September 15, 2023
Health
The top decongestant on the market doesn’t actually decongest, FDA says
By
Matthew Perrone
and
The Associated Press
September 12, 2023
Health
Tylenol poisoning suspect who tried to extort $1 million from Johnson & Johnson to ‘stop the killing’ dies at 76
By
Mark Pratt
and
The Associated Press
July 11, 2023
Leadership
From free Stanford courses at Northrop Grumman to revamped internships at Salesforce, here’s how 9 companies are competing on A.I. talent
By
Paolo Confino
June 26, 2023
Finance
Johnson & Johnson offers $8.9 billion settlement to roughly 60,000 people who claim its talc products gave them cancer
By
Jef Feeley
,
Steven Church
and
Bloomberg
April 5, 2023
Health
Johnson & Johnson is paying $17.3 billion to buy a company that helps your heart pump blood
By
Madison Muller
and
Bloomberg
November 1, 2022
Conferences
Chief diversity officers on the key to leveling the corporate playing field
By
Kristine Gill
September 16, 2022
Most Popular
Success
Nvidia’s CEO Jensen Huang says electricians and plumbers will be needed by the hundreds of thousands in the new working...
By
Preston Fore
Economy
Ford CEO on his ‘epiphany’ after talking to his Gen Z factory workers: They were saying they ‘had to have three jobs’
By
Nick Lichtenberg
Innovation
An MIT roboticist who cofounded Roomba maker iRobot says Elon Musk’s vision of humanoid robots as catchall assistants...
By
Marco Quiroz-Gutierrez